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INTRODUCTION 
It is now 34 years since the first report of Acquired 
immune deficiency syndrome (AIDS) appeared 
1
among homosexuals in Los Angeles, USA .  Over 
this period dramatic progress has been made in the 
battle against Human immunodeficiency virus (HIV) 
in the prevention and treatment arenas both in Nigeria 
and globally. Despite all this progress, new infections 
continue to occur. In 2012, there were an estimated 
2.5 million persons newly infected with HIV 
2globally.  Nearly all new infections (with the 
exceptions of mother-to-child transmissions and 
blood product-related transmissions) occur within 
the context of a discordant relationship - someone 
infected with HIV is passing on the infection to 
someone uninfected with HIV through unprotected 
sexual intercourse. Serodiscordance, in which one 
person in a couple is HIV-infected and the other 
person is HIV-uninfected, is a common phenomenon. 
In a multicentre collaborative study across East and 
Southern Africa, 49% of the enrolled heterosexual 
couples were HIV serodiscordant and in a study done 
in Jos, partner disclosure of HIV status among HIV 
positive mothers serodiscordant rate was noted to be 
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ABSTRACT
BACKGROUND: Serodiscordant couples, have been used to study heterosexual transmission risk because of 
the high frequency of sexual acts that occur in stable relationships. The hormonal changes during pregnancy 
could influence heterosexual transmission in serodiscordant relationships. The prevalence of serodiscordant 
relationship is high in Jos and there are conflicting reports on the incidence of seroconversion among 
serodiscordant couples. Also, the factors responsible for seroconversion are not well understood and the 
foregoing reasons stimulated this study.
METHODOLOGY: This was a prospective cohort study of HIV seropositive pregnant women and their 
seronegative male partners who were attending the antenatal /prevention of mother-to-child transmission of 
HIV clinic of the Jos University Teaching Hospital. 
RESULTS: 
Out of the forty-nine (49) couples studied, only one seroconverted giving an incidence of 1/49 (20.4 per 1000 
couple). The mean gestational age at initial testing was 21.4 weeks and that at repeat testing was 38.8 weeks with 
an average follow up time of 11.49 weeks. The average age was 32.81yrs, out of these 29 had tertiary education 
(59.2%).  The predominant ethnic group was Berom (24.5%) and majority (44.9%) of the participants were civil 
servants. The mean frequency of sexual intercourse per week was 2.55 times, (36.7%) do not use condoms during 
sexual intercourse and only (9.7%) always use condom during sexual intercourse.
CONCLUSION:
The incidence of HIV transmission to the male uninfected partner in a serodiscodant setting in Jos during 
pregnancy is low but its occurrence in this study suggests the need to re-test the seronegative male partners after 
every pregnancy.
KEY WORDS: pregnancy, human immunodeficiency virus, serodiscordance, seroconversion  
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34.6% while in Port Harcourt, Nigeria, the 
prevalence of serodiscordance was even higher, 
about 48%, among couples receiving antiretroviral 
1 6
therapy.  HIV transmission within stable 
serodiscordant partnerships is thought to contribute 
substantially to the HIV epidemic in sub-Saharan 
14Africa . In 2012, 34.0 million people were living 
with HIV of whom 15.7 million are women and some 
of their partners are HIV seronegative.
In sub-Saharan Africa, women account for 60% of 
4
HIV infected adults . Many African countries with 
high HIV, fertility rates and women are pregnant for a 
5
substantial portion of their adult years . Physiologic 
changes during gestation – including high levels of 
progesterone which can induce systemic or genital 
5 6 mucosal immunologic changes   – may increase the 
risk for women to acquire HIV during pregnancy and 
pregnant HIV infected women to transmit to their 
sexual partners. Unprotected sex associated with 
efforts to conceive and continued during pregnancy 
7
may also increase HIV risk.
Over the decade the epidemic once dominated by 
infected males has become progressively feminized, 
the number of children infected is also growing and 
the need for an effective and comprehensive 
approach for the prevention of HIV transmission 
3among serodiscordant couples.   Studies have 
estimated that in several sub-Saharan African  
countries, approximately two-thirds of infected 
couples are serodiscordant. Therefore, developing 
effective HIV prevention interventions that target 
serodiscordant couples could potentially contribute 
to reducing HIV transmission in Nigeria. Moreover, 
provision of services to HIV serodiscordant couples 
to help them manage their status is an essential 
8
component of comprehensive HIV responses .
The risk of HIV heterosexual transmission through 
unprotected intercourse depends on many factors, 
including the frequency of intercourse, sexual 
practices (i.e., vaginal vs. anal intercourse), presence 
of concurrent STIs such as genital ulcerative disease, 
HIV virus load in plasma, semen and vaginal 
secretions, disease stage and CD4 cell count, use of 
antiretroviral therapy, particularly highly active 
antiretroviral therapy (HAART), and other factors 
9
such as personal hygiene and male circumcision . It is 
possible that the HIV epidemic is fuelled by several 
factors, including early initiation of sexual activity, 
overall lack of adherence to condoms and the 
10
frequent presence of multiple sexual partners . 
HAART has been clearly demonstrated to be of 
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profound benefit to patients with HIV by prolonging 
and improving their quality of life. Nevertheless, in 
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VARIABLE FREQUENCY PERCENTAGE 
Age(years)   
25-29 15 30.6 
30-34 12 24.5 
35-39 21 42.9 
40-44 1 2.0 
Educational level   
Primary 4 8.2 
Secondary 16 32.7 
Tertiary 29 59.2 
Ethnicity   
Berom 12 24.5 
Hausa 4 8.2 





















































Table 2: FACTORS ASSOCIATED WITH RISK OF TRANSMISSION  
VARIABLES  FREQUENCY PERCENTAGE 
Freq Of Sexual 
Intercourse/Week 
  
1 15 30.6 
2 8 16.3 
3 13 26.5 
4 11 22.4 
5 1 2.0 
6 1 2.0 
Number Of Sexual 
Partners 
  
1 47 96.0 
3 1 2.0 
4 1 2.0 
1 47 96.0 
STI Symptoms   
No 47 95.9 
Yes  2 4.1 
Use During Coitus   
No 18 36.7 
Yes  31 63.3 
Freq Of Use    
Always  3 9.7 
Occasionally  28 92.3 
TOTAL  31 100.0 
Smoking    
No 48 98.0 
Yes  1 2.0 


























































The incidence of seroconversion in study participants is 1/49×100 = 0.020
The mean gestational age at start of study =21.4weeks, SD =7.1weeks
The mean gestational age at the repeat test result = 38.8 weeks, SD = 2.2 weeks
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Table 4:  FACTORS ASSOCIATED WITH TRANSMISSION 2  
VARIABLES  NEGATIVE POSITIVE TOTAL 
CD4 Count     
<350 11 1 12 
>350 37 0 37 
RR   0.91677 , CI = 0.7729 – 1.0872  ,Fisher exact  0.2449 
 
Viral Load    
Detectable 32 1 33 
Undetectable 16 0 16 
RR 0.9697,   CI 0.9129 - 1.0300 ,Fisher exact   0.6735 
 
Use of Condom 
During Coitus 
   
No 18 0 18 
Yes  30 1 31 
RR =1.0333,   CI = 0.9690 - 1.1019 
STI Symptoms    
No 46 1 47 
Yes  2 0 2 
RR = 0.9789   CI = 0.9383 - 1.0209, Fisher exact   0.9592 
Smoking    
No 47 1 48 
Yes  1 0 1 
RR = 0.9792     CI  =  0.9396  -  1.0204, Fisher exact   0.9796 
Take Alcohol     
No 43 1 44 
Yes  5 0 5 
RR = 0.9773,   CI  =  0.9342 - 1.0223, Fisher exact  =  0.8980 
 
DISCUSSION
Pregnancy is associated with increased risk of 
transmission to seronegative male partners because 
of hormonal changes and increase in genital viral 
17
shedding.  In this study the incidence of 
seroconversion among seronegative male partners 
was 1/49 (20.4 per 1000 couple). This incidence is 
low and not statistically significant but for a disease 
of important public health implication of this 
magnitude and small study sample size it is clinically 
significant in the advocacy of reducing transmission 
in a high prevalence setting like Jos. Previous studies 
have reported seroconversion rates of 3.46 per 100 
persons/year during pregnancy among Sub- Saharan 
African women but in that study, the sample size was 
quite bigger, duration of follow up was extended to 
puerperium and among most of the male seronegative 
partners some of their pregnant seropositve partners 
were not on drugs (ARVS). This might be responsible 
7
for this high rate of transmission.  
Another study in China reported a seroincidence of 
1.17 per 100 person-years which is still higher than 
 
this study in Jos; again, the study was done in non-
pregnant HIV positive and their seronegative male 
19
partners compared.  Other studies have reported 
18seroconversion rates of 10.9 per 100 woman years.  
This is quite higher than the incidence in this study 
but the study attempted at comparing rural and urban 
settings and adjusted risk was similar to a study in 
China. 
The mean follow-up time in this study was 18.59 
weeks with standard deviation of 6.62 weeks and 
mean gestational age at presentation was 21.4 weeks. 
This has a significant clinical correlation with late 
antenatal presentation of our women generally and is 
worth noting. The significance of this is in 
counselling patients on early antenatal visits, 
especially for patients that hitherto do not know their 
HIV status. 
The risk of HIV heterosexual transmission include 
the frequency of intercourse, sexual practices, 
presence of concurrent STIs such as genital ulcerative 
disease, HIV virus load in plasma, vaginal secretions, 
disease stage, CD4 cell count, use of antiretroviral 
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therapy, particularly highly active antiretroviral 
therapy (HAART), and other factors such as personal 
hygiene and male circumcision. Another key 
determinant of prevention of transmission among 
serodiscordant couple is the correct, consistent use of 
condoms. In this study, the mean frequency of sexual 
intercourse was 2.55 times per week and only two of 
the patients had history suggestive of STI (4.1%) 
which may be responsible for the low incidence rate. 
Despite the high awareness and investment in 
advocacy in prevention of new infections by use of 
barrier contraception (condom), most of the 
participants were not using it (36.7%). Among those 
using condoms only a few used it consistently and 
correctly (9.7%), majority used it occasionally .This 
study is quite timely and apt at this critical period to 
put all hands on deck to redouble our campaign for 
the use of barrier contraceptives. In a study done in 
Lusaka, Zambia on condom and nonoxynol-9 use, the 
incidence of HIV infection in serodiscordant couples 
and the rate of seroconversion was higher among 
those who used condoms less likely (10.7/100) 
compared to those who used condoms (2.3/100). 
Another work done in 2002 on condom effectiveness 
in reducing heterosexual HIV transmission also 
revealed that correct and consistent use of condoms 
can substantially reduce the rate of transmission. 
Weller S et al in a study on condom effectiveness in 
reducing heterosexual HIV transmission also 
concluded that consistent use of condom resulted in 
an 80% reduction in HIV incidence.
Substance abuse, alcohol consumption and cigarette 
smoking are associated with an increased risk of HIV 
infection. These substances may increase HIV risk by 
reducing users' inhibitions to engage in risky sexual 
behaviours. In this study, most of the participants 
neither took alcohol nor smoked cigarettes. Even 
when adjusted, it was not statistically significant but 
this may be due to a small sample size.
 The main determinants of transmission in this study 
would appear to be a detectable viral load and a low 
CD4 cell count as the only case of seroconversion 
during pregnancy occurred in this category of 
participants. Although this was not statistically 
significant, and no seroconversion was seen among 
partners when the CD4 cell count was above 350, it 
does call for longer observations in a bigger cohort.  
Consideration must be given to the use of 
antiretroviral therapy as HIV prevention in 
serodiscordant settings in Nigeria since this has been 
shown to secure virologic suppression and block 
20
transmission in up to 96% of cases.
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CONCLUSION 
The incidence of HIV transmission to the male 
uninfected partner in a serodiscodant setting in Jos 
during pregnancy is low but its occurrence in this 
study suggests the need to re-test the negative male 
partners after every pregnancy.
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